Treatment of tuberculosis in HIV-infected patients:: safety and antiretroviral efficacy of the concomitant use of ritonavir and rifampin

被引：25
|
作者：
Moreno, S [1 ]
Podzamczer, D
Blázquez, R
Iribarren, JA
Ferrer, E
Reparaz, J
Peña, JM
Cabrero, E
Usán, L
机构：
[1] Hosp Ramon & Cajal, Dept Infect Dis, E-28034 Madrid, Spain
[2] Bellvitge Hosp, Dept Infect Dis, Barcelona, Spain
[3] Hosp Morales Meseguer, Dept Microbiol & Infect Dis, Murcia, Spain
[4] Hosp NS Aranzazu, Dept Infect Dis, San Sebastian, Spain
[5] Hosp Navarra, Dept Infect Dis, Pamplona, Spain
[6] Hosp La Paz, AIDS Unit, Madrid, Spain
[7] Abbott Labs, Dept Med, Madrid, Spain
来源：
AIDS | 2001年 / 15卷 / 09期
关键词：
D O I：
10.1097/00002030-200106150-00018
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：1185 / 1187
页数：3
相关论文
共 50 条
  • [31] Antiretroviral therapy in HIV-infected patients with tuberculosis and chronic viral hepatitis
    Kanestri, V
    Kravchenko, A.
    Deulina, M.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15 : 153 - 154
  • [32] The clinical pharmacokinetics of rifampin and ethambutol in HIV-infected persons with tuberculosis
    Perlman, DC
    Segal, Y
    Rosenkranz, S
    Rainey, PM
    Remmel, RP
    Salomon, N
    Hafner, R
    Peloquin, CA
    CLINICAL INFECTIOUS DISEASES, 2005, 41 (11) : 1638 - 1647
  • [33] Second-Line Antiretroviral Treatment Outcome in HIV-Infected Patients Coinfected with Tuberculosis in Pakistan
    Shafiq, Muhammad
    Zafar, Sana
    Ahmad, Aftab
    Kazmi, Abeer
    Fatima, Alina
    Mujahid, Tanvir Ahmed
    Qazi, Rizwan
    Akhter, Nasim
    Shahzad, Amir
    Rehman, Saif Ur
    Shereen, Muhammad Adnan
    Hyder, Muhammad Zeeshan
    BIOMED RESEARCH INTERNATIONAL, 2023, 2023
  • [34] Survival of a large cohort of HIV-infected tuberculosis patients in the era of highly active antiretroviral treatment
    Catala, L.
    Orcau, A.
    de Olalla, P. Garcia
    Millet, J-P.
    Rodriguez-Mondragon, A.
    Cayla, J. A.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2011, 15 (02) : 263 - 269
  • [35] Antiretroviral Treatment-Associated Tuberculosis in a Prospective Cohort of HIV-Infected Patients Starting ART
    Worodria, William
    Massinga-Loembe, Marguerite
    Mayanja-Kizza, Harriet
    Namaganda, Jane
    Kambugu, Andrew
    Manabe, Yukari C.
    Kestens, Luc
    Colebunders, Robert
    CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2011,
  • [36] Efficacy of syphilis treatment in HIV-infected patients
    Vehring, Justus
    Sammet, Stefanie
    von Heinegg, Evelyn Heintschel
    Schadendorf, Dirk
    Esser, Stefan
    INFECTION, 2021, 49 (SUPPL 1) : S40 - S40
  • [37] Outcomes in HIV-infected patients who develop tuberculosis after starting antiretroviral treatment in Malawi
    Yu, J. K-L.
    Bong, C-N.
    Chen, S. C-C.
    Dzimadzi, R.
    Lu, D-Y.
    Makombe, S. D.
    Schouten, E. J.
    Kamoto, K.
    Harries, A. D.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2008, 12 (06) : 692 - 694
  • [38] Efficacy and safety of antiretrovirals in HIV-infected patients with cancer
    Torres, H. A.
    Rallapalli, V.
    Saxena, A.
    Granwehr, B. P.
    Viola, G. M.
    Ariza-Heredia, E.
    Adachi, J. A.
    Chemaly, R. F.
    Marfatia, R.
    Jiang, Y.
    Mahale, P.
    Kyvernitakis, A.
    Fanale, M. A.
    Mulanovich, V.
    CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 (10) : O672 - O679
  • [39] Saquinavir/ritonavir have better short term antiviral efficacy than either ritonavir or indinavir in HIV-infected antiretroviral naive patients.
    Gerstoft, J
    Kirk, O
    Katzenstein, T
    Mathiesen, L
    Nielsen, H
    Lundgren, JD
    Pedersen, C
    AIDS, 1998, 12 : S9 - S9
  • [40] Management of HIV-infected pregnant patients in malaria-endemic areas: Therapeutic and safety considerations in concomitant use of antiretroviral and antimalarial agents
    Okereke, CS
    CLINICAL THERAPEUTICS, 1999, 21 (09) : 1456 - 1496
12345